Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 115.43%12.5M | 1,669.47%87.34M | 109.14%1.07M | -484.14%-36.9M | 53.49%-39M | -30.03%-80.97M | -78.37%4.94M | 55.06%-11.65M | -56.12%9.61M | -3.46%-83.86M |
Net income from continuing operations | -19.29%-240.71M | 16.52%-48.08M | 29.48%-40.07M | -39.63%-91.09M | -177.80%-61.47M | -208.98%-201.78M | -35.44%-57.6M | -3,772.87%-56.82M | -1,083.97%-65.24M | -40.04%-22.13M |
Operating gains losses | 56.86%36.6M | -52.69%3.12M | 69.84%9.2M | 309.76%22.8M | -74.14%1.49M | -14.76%23.33M | -67.53%6.58M | 51.64%5.42M | 117.05%5.56M | 501.67%5.77M |
Depreciation and amortization | -21.58%30.48M | -23.32%6.96M | -19.67%7.7M | -33.97%6.93M | -8.46%8.9M | -14.54%38.87M | -19.76%9.07M | -10.67%9.58M | -10.28%10.49M | -17.28%9.72M |
Deferred tax | 70.71%-3.46M | 98.46%-152K | -147.20%-892K | 96.04%-141K | -751.31%-2.27M | -202.80%-11.81M | -272.02%-9.87M | -20.85%1.89M | -197.91%-3.56M | 3.61%-267K |
Other non cash items | 1,922.33%84.78M | 464.59%20.55M | 8,635.44%20.7M | 10,405.08%24.79M | 23,608.86%18.73M | --4.19M | --3.64M | --237K | --236K | --79K |
Change In working capital | 197.25%98.14M | 106.67%103.57M | -38.54%2.79M | -102.14%-1.24M | 91.25%-6.97M | 134.26%33.02M | 111.17%50.11M | 110.10%4.53M | 908.26%58.08M | 1.60%-79.71M |
-Change in receivables | -196.81%-16.98M | 194.96%10.05M | -205.35%-10.28M | -250.32%-24.4M | 260.16%7.66M | 141.73%17.54M | -105.48%-10.58M | 79.60%9.76M | 239.42%16.24M | 106.93%2.13M |
-Change in inventory | -66.22%632K | 86.45%-608K | -31.14%909K | -23.20%5.8M | -117.54%-5.47M | 392.80%1.87M | -240.26%-4.49M | 184.51%1.32M | 101.33%7.55M | 58.29%-2.51M |
-Change in prepaid assets | -90.03%1.3M | -63.42%3.43M | -127.92%-531K | -110.43%-855K | 88.49%-744K | 240.51%13M | 198.94%9.37M | 390.83%1.9M | -4.31%8.2M | 16.07%-6.47M |
-Change in payables and accrued expense | 116.71%13.79M | -16.60%-38.63M | 180.06%27.23M | 114.34%31.05M | 80.43%-5.85M | -165.56%-82.56M | -286.24%-33.13M | -82.34%-34.01M | 280.20%14.49M | -34.81%-29.92M |
-Change in other current assets | 309.93%15.33M | 241.96%6.93M | 40.64%4.36M | 332.88%11.85M | -1,697.47%-7.8M | -517.79%-7.3M | -224.37%-4.88M | 150.30%3.1M | -220.37%-5.09M | -78.60%-434K |
-Change in other current liabilities | -126.68%-529K | 235.00%81K | -3.13%279K | -189.88%-1.15M | -46.46%257K | 3,461.02%1.98M | 91.54%-60K | -8.28%288K | 2,002.99%1.28M | 19.11%480K |
-Change in other working capital | -4.40%84.6M | 30.29%122.32M | -186.47%-19.17M | -252.67%-23.53M | 111.59%4.98M | 687.63%88.49M | 563.68%93.88M | 193.94%22.17M | 71.98%15.42M | -195.07%-42.98M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 115.43%12.5M | 1,669.47%87.34M | 109.14%1.07M | -484.14%-36.9M | 53.49%-39M | -30.03%-80.97M | -78.37%4.94M | 55.06%-11.65M | -56.12%9.61M | -3.46%-83.86M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -12.45%-26.2M | 79.69%-4.12M | -281.16%-6.67M | -108.25%-7.12M | -152.98%-8.29M | -23.73%-23.3M | -176.44%-20.29M | 205.80%3.68M | -37.09%-3.42M | 40.63%-3.28M |
Net PPE purchase and sale | 27.50%-26.2M | 79.69%-4.12M | 27.08%-6.67M | -108.25%-7.12M | -152.98%-8.29M | -91.89%-36.14M | -176.44%-20.29M | -162.84%-9.15M | -37.09%-3.42M | 40.63%-3.28M |
Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | --12.84M | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -12.45%-26.2M | 79.69%-4.12M | -281.16%-6.67M | -108.25%-7.12M | -152.98%-8.29M | -23.73%-23.3M | -176.44%-20.29M | 205.80%3.68M | -37.09%-3.42M | 40.63%-3.28M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -58.22%50.96M | -175.68%-9.81M | 3,309.67%31.37M | 6,932.23%25.53M | -96.40%3.88M | 935.75%121.99M | 848.56%12.97M | 761.87%920K | -96.56%363K | 562.85%107.75M |
Net issuance payments of debt | -64.67%52.68M | -169.24%-9.77M | 3,313.04%31.4M | 6,220.54%25.54M | -95.87%5.52M | 1,189.49%149.13M | 1,313.84%14.12M | 597.30%920K | -96.19%404K | 682.85%133.69M |
Net common stock issuance | 33.49%-1.72M | ---38K | ---31K | 76.47%-8K | 35.62%-1.64M | -169.34%-2.58M | --0 | --0 | 24.44%-34K | -643.15%-2.55M |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---24.55M | ---1.15M | --0 | ---7K | ---23.39M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -58.22%50.96M | -175.68%-9.81M | 3,309.67%31.37M | 6,932.23%25.53M | -96.40%3.88M | 935.75%121.99M | 848.56%12.97M | 761.87%920K | -96.56%363K | 562.85%107.75M |
Net cash flow | ||||||||||
Beginning cash position | 12.90%172.81M | -21.68%136.18M | -38.70%111.04M | -25.61%129.74M | 12.90%172.81M | -39.31%153.07M | 25.13%173.88M | 10.68%181.14M | 23.90%174.41M | -39.31%153.07M |
Current changes in cash | 110.26%37.26M | 3,171.42%73.41M | 465.39%25.76M | -382.35%-18.5M | -310.62%-43.41M | 118.52%17.72M | -117.38%-2.39M | 76.15%-7.05M | -78.13%6.55M | 118.76%20.61M |
Effect of exchange rate changes | -219.38%-2.42M | -245.88%-1.93M | -187.85%-616K | -209.78%-202K | -54.38%333K | 158.67%2.02M | 268.52%1.32M | -104.42%-214K | 102.61%184K | 145.43%730K |
End cash Position | 20.16%207.66M | 20.16%207.66M | -21.68%136.18M | -38.70%111.04M | -25.61%129.74M | 12.90%172.81M | 12.90%172.81M | 25.13%173.88M | 10.68%181.14M | 23.90%174.41M |
Free cash flow | 88.30%-13.7M | 641.97%83.22M | 73.04%-5.61M | -811.44%-44.02M | 45.73%-47.29M | -44.39%-117.11M | -199.17%-15.36M | 29.27%-20.81M | -68.10%6.19M | -0.65%-87.14M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |